Jubilant Pharmova's arm gets EIR with VAI status for Maryland facility

13 Mar 2025 Evaluate

Jubilant Pharmova’s subsidiary -- Jubilant Cadista Pharmaceuticals Inc., USA, (Jubilant Cadista) has received Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI) status from the US Food and Drug Administration (USFDA) for its solid oral formulations facility at Salisbury, Maryland, USA (Facility) with respect to the inspection conducted by the said regulatory agency in January 2025. 

With the receipt of the EIR from the USFDA, the inspection stands successfully closed. Going forward, the said Facility is not expected to manufacture any products as it has closed manufacturing operations. 

Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.


Jubilant Pharmova Share Price

892.70 0.95 (0.11%)
28-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1735.45
Dr. Reddys Lab 1144.05
Cipla 1441.70
Lupin 2026.50
Zydus Lifesciences 885.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...